GB828766A - Medicine for reducing cholesterol level of the blood - Google Patents
Medicine for reducing cholesterol level of the bloodInfo
- Publication number
- GB828766A GB828766A GB10315/58A GB1031558A GB828766A GB 828766 A GB828766 A GB 828766A GB 10315/58 A GB10315/58 A GB 10315/58A GB 1031558 A GB1031558 A GB 1031558A GB 828766 A GB828766 A GB 828766A
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicine
- blood
- cholesterol level
- reducing cholesterol
- hypercholesterolamia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A unit dosage form of a medicament for treating hypercholesterolamia, for example a tablet or capsule, comprises from 50 to 300 mg. of 4 - (3,5 - diiodo - 4 - hydroxy - phenoxy) - 3,5 - diiodobenzoic acid in admixture with a solid pharmaceutical diluent.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US828766XA | 1957-10-28 | 1957-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB828766A true GB828766A (en) | 1960-02-24 |
Family
ID=22174010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB10315/58A Expired GB828766A (en) | 1957-10-28 | 1958-03-31 | Medicine for reducing cholesterol level of the blood |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB828766A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284971A (en) * | 1992-07-16 | 1994-02-08 | Syntex (U.S.A.) Inc. | 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents |
-
1958
- 1958-03-31 GB GB10315/58A patent/GB828766A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284971A (en) * | 1992-07-16 | 1994-02-08 | Syntex (U.S.A.) Inc. | 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB828766A (en) | Medicine for reducing cholesterol level of the blood | |
Pecknold et al. | Lack of indication for use of antiparkinson medication: A follow-up study. | |
GB1464467A (en) | Pharmaceutical composition for the treatment of coronary | |
GB950162A (en) | Medicines for the treatment of hepatic disorders | |
CA586002A (en) | Means for administering medication orally into the respiratory organs | |
FR1056M (en) | Pharmaceutical product intended for the treatment of circulatory disorders of the upper or lower limbs. | |
ES386130A1 (en) | Aminoethanesulfonic acid derivative | |
GB976096A (en) | Pharmaceutical compositions | |
ES352458A1 (en) | Procedure for the preparation of a medication for proteoanabilizing action. (Machine-translation by Google Translate, not legally binding) | |
FR2576M (en) | New drug, in particular for the treatment of blood coagulability disorders. | |
SU109348A1 (en) | Method for expansion of coronary and peripheral vessels | |
GB1128372A (en) | Injectable pharmaceutical compositions | |
ES383340A1 (en) | P-(acetoacetamidoalkyl)benzenesulfonamide derivatives | |
Wang | Amoxicillin/clavulanic-acid | |
GB892784A (en) | Pharmaceutical compositions comprising 3-pyridine acetic acid | |
NL154217B (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS IN WHICH ONE PUTS 11-ALKOXY-3-KETOSTEROIDS WITH AN OXYGEN FUNCTION IN THE 17-PLACE IN MEDICAL USE FORM OF ADMINISTRATION, THE PREPARED MEDICINAL PRODUCTS, AS PREPARED MEDICINAL PRODUCTS, AS PREPARED PREPARATIONS. | |
GB953250A (en) | Pharmaceutical compositions comprising diphospho-pyridine nucleotide or a derivative thereof | |
TATENO | The Treatment of A Case of Stomath Cancer by Oriental Medicine | |
Matsukuma et al. | A Case of Parrot's Pseudoparalysis | |
FR1829M (en) | New drug, in particular for the treatment of blood coagulability disorders. | |
Tsushita | Some Experiences of Hand Surgery | |
GB891445A (en) | Pharmaceutical compositions comprising sulphonamido-thiadiazole derivatives | |
AU225630B2 (en) | Pharmaceutical dosage unit adapted forthe treatment of hypercholesterolemia | |
GB994733A (en) | New anabolically effective pharmaceutical preparations | |
ES276322A1 (en) | Method for the treatment of the affection of drugs (Machine-translation by Google Translate, not legally binding) |